 LEXINGTON, Mass., June 11, 2021 GLOBE NEWSWIRE -- T2 Biosystems, Inc. NASDAQ:TTOO, a leader in the rapid detection of sepsis-causing pathogens, today announced that leading proxy advisory firms Institutional Shareholder Services Inc. ISS and Glass Lewis and Co., LLC Glass Lewis, in addition to the Companys Board of Directors, have recommended that T2 Biosystems stockholders vote in favor of the proposal to amend the Companys Certification of Incorporation to increase the number of authorized shares of common stock the Charter Amendment Proposal at the upcoming annual stockholder meeting to be held on June 25, 2021. 